Will cevumeran start a Phase III trial for pancreatic cancer by 2030?
Basic
2
Ṁ122030
57%
chance
1D
1W
1M
ALL
A phase I trial of cevumeran in pancreatic cancer had some pretty [impressive results](https://www.nature.com/articles/s41586-023-06063-y). By 2030 will cevumeran (in combination with other drugs or not) enter a Phase III trial at least partially targeting pancreatic ductal adenocarcinoma?
This question is managed and resolved by Manifold.
Get
1,000
and3.00
Related questions
Related questions
Will AOH1996 advance past Phase II trials by the end of 2027?
51% chance
Will a senolytic drug be used clinically to slow, prevent, or reverse aging by the end of 2033?
60% chance
Will a cure that eradicated over 50% of cancer tumors without significant adverse side effects be found before 2050?
55% chance
Will cancer be cured by 2035?
17% chance
Will we get a cure for cancer before 2037?
23% chance
Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
19% chance
Will we get a cure for cancer before 2038?
36% chance
Will we get a cure for cancer before 2031?
16% chance
Will we get a cure for cancer before 2035?
21% chance
Will a cure for cancer happen before 2030
29% chance